Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline
Repare Therapeutics has three cancer drug candidates in the clinic and another one expected to enter Phase 1 by the ...
Repare Therapeutics has three cancer drug candidates in the clinic and another one expected to enter Phase 1 by the ...
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...
A Ludwig Cancer Research study has identified a metabolic switch in the immune system's T cells that is essential to ...
AI startup Paige launched a new AI product this week. The New York City-based company unveiled an AI-powered biomarker module ...
Hackensack Meridian Health announced it launched a cancer risk and early detection program at the health system’s Hennessy Institute for ...
Summary of current small molecular drugs targeting PD-L1 and CD47. Small molecule chemical compounds block the function of major immune ...
Credit: Cancer Biology & Medicine (2024). DOI: 10.20892/j.issn.2095-3941.2023.0395 The saga of cancer treatment is marked by a relentless pursuit of ...
Credit: Unsplash/CC0 Public Domain Ovarian cancers are often found when they are already advanced and hard to treat. Researchers have ...
Antibody drugs that go after two targets have already made their mark in blood cancers, but the field is working ...
Credit: Pixabay/CC0 Public Domain A worrying new study by the American Cancer Society has revealed that generation X and millennials ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.